Financials

  • Market Capitalization 1.82 B
  • Employee 167
  • Founded 2019
  • CEO N/A
  • Website www.zenasbio.com
  • Headquarter Delaware, United States
  • FIGI BBG01J1MG9D6
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-4.3
Price to sales ratio
162.41

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
2055
PGEN
Precigen, Inc. - Common Stock
5.12 USD-0.97%-5.19%+11.30%+161.22%1.83 B USD
2057
ANAB
AnaptysBio, Inc. - Common Stock
62.51 USD-10.46%-6.55%+10.36%+77.59%1.82 B USD
2060
STOK
Stoke Therapeutics, Inc. - Common Stock
29.13 USD-1.12%-11.32%-4.46%+140.55%1.81 B USD
2071
ZYME
Zymeworks Inc. - Common Stock
24.66 USD-1.12%-7.36%+7.12%+39.01%1.80 B USD

Frequently asked questions about Zenas BioPharma, Inc. - Common Stock

What is the Zenas BioPharma, Inc. - Common Stock stock price today?

The current price of Zenas BioPharma, Inc. - Common Stock (ZBIO) is 28.78. Over the past 24 hours, the stock has changed by +3.23%. Follow the ZBIO chart for real-time price dynamics.

What is the stock ticker of Zenas BioPharma, Inc. - Common Stock?

Zenas BioPharma, Inc. - Common Stock trades under the ticker ZBIO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Zenas BioPharma, Inc. - Common Stock stock going up?

ZBIO has changed by +5.19% over the last week, +39.64% over the last month, and +8.77% over the last year. Review the chart to see whether the current move is part of a broader trend.

Does Zenas BioPharma, Inc. - Common Stock release financial reports?

Yes. You can track Zenas BioPharma, Inc. - Common Stock financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.

What was Zenas BioPharma, Inc. - Common Stock net income for the last quarter?

Zenas BioPharma, Inc. - Common Stock reported net income of -80.99 M for the last quarter. The previous quarter showed -240.44 M, which means net income changed by +66.32%.

How many employees does Zenas BioPharma, Inc. - Common Stock have?

As of the latest available data, Zenas BioPharma, Inc. - Common Stock has 167 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Zenas BioPharma, Inc. - Common Stock stock?

You can buy Zenas BioPharma, Inc. - Common Stock (ZBIO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Zenas BioPharma, Inc. - Common Stock stock?

Investing in Zenas BioPharma, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ZBIO chart and related analysis on metatrader.com as part of your research.